Home > A. Molecular pathology > ASPL-TFE3

ASPL-TFE3

Monday 8 March 2004

Pathology

- TFE3/ASPL gene fusion by t(X;17)(p11;q25) in juvenile renal cell carcinoma and alveolar soft part sarcoma (#12769020#, #11438465#, #11244503#)

FFPE

- ASPL-TFE3 fusion transcript detection from paraffin-embedded tumor tissues. (#18382356#)

References

- Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues. Pang LJ, Chang B, Zou H, Qi Y, Jiang JF, Li HA, Hu WH, Chen YZ, Liu CX, Zhang WJ, Li F. Diagn Mol Pathol. 2008 Dec;17(4):245-52. PMID: #18382356#

- Tonk V, Wilson KS, Timmons CF, Schneider NR, Tomlinson GE. Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype. Cancer Genet Cytogenet. 1995 May;81(1):72-5. PMID: #7773963#

- Tomlinson GE, Nisen PD, Timmons CF, Schneider NR. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet. 1991 Nov;57(1):11-7. PMID: #1684532#